The effects of the internet on pharmaceutical consumers and providers

Disease Management and Health Outcomes

Volumn 10, Issue 11, 2002, Pages 679-691

  Dupuits, François M H M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; AMPHETAMINE; CANNABIS; COCAINE; ILLICIT DRUG; KETAMINE; LYSERGIDE; OPIATE; PHENCYCLIDINE; PSYCHEDELIC AGENT;

ADVERSE DRUG REACTION; COMPUTER NETWORK; CONFIDENTIALITY; CONSULTATION; CONSUMER; DECISION MAKING; DISEASE MANAGEMENT; DOCTOR PATIENT RELATION; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; ELECTRONIC MEDICAL RECORD; HEALTH CARE COST; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; INTERNET; LAW; MEDICAL INFORMATION; PATIENT CARE; PHARMACEUTICAL CARE; PRIVACY; PURCHASING; REVIEW; SELF CARE; TELECOMMUNICATION;

EID: 0036421576     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200210110-00002     Document Type: Review

References (71)

1. Gentile J.A. Databases, websites, and the Internet. Oncology (Huntingt) 1998 Nov; 12 (11A): 356-9
2. Navarro R.P. Internet pharmacies: Opportunities and challenges. Manag Care Interface 1999 Jun; 12 (6): 64, 66-7
3. Dupuits F.M.H.M. The role of community health information networks in disease management. Dis Manage Health Outcomes 2000 Oct; 8 (4): 185-95
4. D'Emanuele A. Are you being pushed? PharmWeb: News from the Internet [online] 1997 Nov/Dec; 11 (6). Available from URL: http://www.pharmweb.net/pwmirror/pwf/pharmwebf38.html [Accessed 2002 Oct 3]
5. D'Emanuele A. Interactivity. PharmWeb: News from the Internet 1997 [online] Jul/Aug; 11 (4). Available from URL: http://www.pharmweb.net/pwmirror/pwf/pharmwebf36.html [Accessed 2002 Oct 3]
6. Angaran D.M. Telemedicine and telepharmacy: Current status and future implications. Am J Health Syst Pharm 1999 Jul 15; 56: 1405-26
7. Frank S.R. Digital health care: The convergence of health care and the Internet. J Ambulatory Care Manage 2000 Apr; 23 (2): 8-17
8. Dupuits F.M.H.M Diagnostic Decision Support for General Practitioners [dissertation]. Maastricht: Maastricht University, 1997
9. Breeuwer M., Wadley J.P., De Bliek H.L., et al. The EASI project: Improving the effectiveness and quality of image-guided surgery. IEEE Trans Inf Technol Biomed 1998 Sep; 2 (3): 156-68
10. Thornton P.D., Simon S., Mathew T.H. Towards safer drug prescribing, dispensing and administration in hospitals. J Qual Clin Pract 1999 Mar; 19 (1): 41-5
11. Bolton P., Douglas K., Booth B., et al. A relationship between computerisation and quality in general practice. Aust Fam Physician 1999 Sep; 28 (9): 962-5
12. Gerlach K., Kaeding A., Kottmair S., et al. The implementation of a quality-net as a part of the European project DIABCARE Q-Net. IEEE Trans Inf Technol Biomed 1998 Jun; 2 (2): 98-104
13. Dissanayake V.H., Jayasekara R.W. Pattern of use of medical information made available via an Internet website. Ceylon Med J 1999 Mar; 44 (1): 14-7
14. Zura A., Smith M.P. Medical resources for the anesthesiologist on the Internet. Reg Anesth Pain Med 2000 Jan-Feb: 25 (1): 99-102
15. Weiss S.R., Cooke C.E., Bradley L.R., et al. Pharmacist's guide to pregnancy registry studies. J Am Pharm Assoc 1999 Nov/Dec; 39 (6): 830-4
16. Jones D. Web alert: Molecular vaccines for disease prevention and therapy. Curr Opin Mol Ther 2001; 3 (1): 11-2
17. Sica J.M. Managing prescription drug costs. Employee Benefits J 2001 Mar; 26 (1): 35-40
18. Miller T.E., Reents S. The Health Care Industry in Transition: The Online Mandate to Change [Online]. Internet Strategies Group Cyber Dialogue Inc; 1998. Available from URL: http://www.cyberdialogue.com/pdfs/wp/wp-cch-1999-transition.pdf [Accessed 2002 Oct 10]
19. Peterson A.M. A survey of selected Internet pharmacies in the United States. J Am Pharm Assoc 2001 Mar/Apr; 41 (2): 205-12
20. Ukens C. Internet pharmacies. Drug Topics 1999 May; 17: 63-70
21. Latner A.W. Pharmacists on the Internet: How to attract customers. Pharm Times 1998; 64: 78
22. Landis N.T. Virtual pharmacies boast easy access, privacy safeguards. Am J Health Syst Pharm 1999; 56: 1174, 1177-9
23. Field M.J., editor. Telemedicine: A Guide to Assessing Telecommunications in Health Care. Institute of Medicine, Washington (DC): National Academy Press, 1996
24. National Association of Boards of Pharmacy. VIPPSTM Information and Verification Site. Available from URL: http://www.nabp.net/vipps/intro.asp [Accessed 2002 Oct 3]
25. National Association of Boards of Pharmacy. VIPPSTM Disclaimer. Available from URL: http://www.nabp.net/vipps/vippsDisclaimer.asp [Accessed 2002 Oct 3]
26. Marwick C. Several groups attempting regulation of Internet Rx. JAMA 1999; 281: 975-6
27. Paulsen M. New NABP program combines criteria, inspections to certify online pharmacy quality. J Am Pharm Assoc 1999; 38: 870
28. National Association of Boards of Pharmacy Model Pharmacy Act. Definitions, Section 1 Gg., 1998. Available from URL: http://www.nabp.net [Accessed 2002 Oct 3]
29. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: Meta-analysis of prospective studies. JAMA 1998; 279: 1200-5
30. Ozdemir V., Shear N.H., Kalow W. What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects? Drug Saf 2001; 24 (2): 75-85
31. Cobert B., Silvey J. The Internet and drug safety: What are the implications for pharmacovigilance? Drug Saf 1999 Feb; 20 (2): 95-107
32. Bogenschutz M.P. Drug information libraries on the Internet. J Psychoactive Drugs 2000 Sep; 32 (3): 249-58
33. Halpern J.H., Pope H.G. Hallucinogens on the Internet: A vast new source of underground drug information. Am J Psychiatry 2001 Mar; 158 (3): 481-3
34. Graeme K.A. New drugs of abuse. Emerg Med Clin North Am 2000 Nov; 18 (4): 625-36
35. Shannon M., Quang L.S. Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. Pediatr Emerg Care 2000; 16 (6): 435-40
36. Agar M., Bourgois P., French J., et al. Buprenorphine: "Field trials" of a new drug. Qual Health Res 2001 Jan; 11 (1): 69-84
37. Dayton C.S., Ferguson J.S., Hornick DB, et al. Evaluation of an Internet-based decision-support system for applying the ATS/CDC guidelines for tuberculosis preventive therapy. Med Decis Making 2000 Jan-Mar; 20 (1): 1-6
38. Cauchon M., Leduc Y. Trouver la bonne information au bon moment: Partie I: Médication, livres de référence, guides de pratique. Can Fam Physician/Le Médicin de Famille Canadien 2001 Feb; 47: 348-9
39. Knapp K.K., Blalock S.J., O'Malley C.H. ASHP survey of ambulatory care responsibilities of pharmacists in managed care and integrated health systems, 1999. Am J Health Syst Pharm 1999 Dec 1; 56: 2431-43
40. Mehl B., Santell J.P. Projecting future drug expenditures, 2000. Am J Health Syst Pharm 2000 Jan 15; 57: 129-38
41. Hensley S. GPOs under pressure to deliver: Purchasing volume climbs, but Internet firms and independents are challenging the large groups. Mod Healthc 1999 Sep 20; 29 (38): 38-47
42. Salazar A., Howells J. Creating knowledge structures in the pharmaceutical industry: the increasing significance of virtual organisation. World Hosp Health Serv 2000; 36 (2): 6-10
43. Gambardella A. Science and Innovation: The US Pharmaceutical Industry during the 1980s. Cambridge: Cambridge University Press, 1995
44. Randle K., Rainnie A. Creativity and Control in a Pharmaceutical R&D Company: The Case of Glaxo Research and Development. University of Hertfordshire Business School, 1994. Working paper series no.: 7
45. Della Valle F., Gambardella A. Biological revolution and strategies for innovation in pharmaceutical companies. R&D Manage 1993; 23 (4)
46. Rau R. Outline for a nationwide co-operation in planning and performing multi-center studies in rheumatology [in German]. Ztschr Rheumatol 2000; 59 (1): 50-2
47. Mann H.J. Pharmacy technology of the ICU: Today and tomorrow. Crit Care Clin 2000 Oct; 16 (4): 641-58
48. Malone T., Laubacher R. The dawn of the e-lance economy: Are big companies becoming obsolete? Harv Bus Rev 1998 Sep-Oct: 145-52
49. Timmers P. Electronic commerce: Strategies and models for business-to-business trading. Wiley Series in Information Systems. Chichester: Wiley & Sons, 1999
50. Iansiti M., Maccormack A. Developing products on Internet time. Harv Bus Rev 1997 Sep-Oct: 108-24
51. Prahalad C., Hamel G. The core competence of the corporation. Harv Bus Rev 1990; 68: 79-91
52. Chiesa V., Manzini R. Managing virtual R&D organizations: Lessons from the pharmaceutical industry. Int J Technol Manage 1997; 13: 471-85
53. Staropoli C. Cooperation in R&D in the pharmaceutical industry: The network as an organizational innovation governing technological innovation. Technovation 1998; 18 (1): 13-23
54. Howells J. Going global: The use of ICT networks in research and development. Res Policy 1995; 24: 169-84
55. D'Emanuele A. The Internet: A tool for delivering and exchanging information. Int Pharm J 1998; 10: 129-34
56. D'Emanuele A. Pharmweb: Pharmaceutical information on the Internet. Pharm Sci Technol Today 1998; 1: 2-4
57. D'Emanuele A. The Internet. Pharm J 1998; 260: 26-8
58. D'Emanuele A. Pharmweb: Pharmaceutical information on the Internet. In: Bakker S, editor. Health Information Management: What Strategies. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1997: 219-23
59. D'Emanuele A. The Internet: A global communication tool. Int Pharm J 1995; 9 (2): 68-72
60. Appleby C. E-health & pharmaceuticals. Health Forum J 2001 Jan-Feb; 44 (1): 17-21
61. World Health Organization. The UMC - The Global Intelligence Network for Benefits and Risks in Medicinal Products. Available from URL: http://www.who-umc.org/home/html [Accessed 2002 Sep 6]
62. European Union. International Conference on Harmonisation. Available from URL: http://www.ich.org [Accessed 2002 Sep 6]
63. D'Emanuele A. How Secure is the Internet? PharmWeb: News from the Internet 1997 May/Jun; 11 (3). Available from URL: http://www.pharmweb.net/pwmirror/pwf/pharmwebf35.html [Accessed 2002 Oct 3]
64. D'Emanuele A. Is Someone Watching You? PharmWeb: News from the Internet 1997 Sep/Oct; 11 (5). Available from URL: http://www.pharmweb.net/pwmirror/pwf/pharmwebf37.html [Accessed 2002 Oct 3]
65. California HealthCare Foundation. Privacy: Report on the Privacy Policies and Practices of Health Web Sites. Oakland (CA): California HealthCare Foundation, 2000 Jan
66. European Commission. Information Society Website. Available from URL: htttp://europa.eu.int/ISPO/legal/en/dataprot/dataprot.html [Accessed 2002 Oct 3]
67. European Union. International Conference on Harmonisation. E2B Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety. Available from URL: http://www.ich.org/1bis.html [Accessed 2002 Sep 6]
68. European Union. International Conference on Harmonisation. M2 Multidisciplinary Group 2: Electronic Standards for the Transfer of Regulatory Information. Available from URL: http://www.ich.org/ich5.html [Accessed 2002 Sep 6]
69. European Union. International Conference on Harmonisation. M1 International Medical Terminology/Medical Dictionary for Regulatory Activities. Available from URL: http://www.ich.org/ich5m.html [Accessed 2002 Oct 3]
70. EC Council Directive 92/28/EEC concerning the advertising of medicinal products for human use. Official Journal of the European Communities, 1992, L113, 13 [online]. Available from URL: European Union Document Delivery Service http://www.eudor.eur-op.eu.int [Accessed 2002 Oct 3]
71. US Food and Drug Administration. FDA Internet guidance. The Pink Sheet 1997; 59 (21): 7